ZNF8 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.95239396766556E-13 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.56049999999741E-06 |
Normal-vs-Stage2 |
3.232900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.592100E-04 |
Stage1-vs-Stage2 |
6.089000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.995200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.693400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.37919717050295E-11 |
Normal-vs-AfricanAmerican |
5.481700E-02 |
Normal-vs-Asian |
6.709900E-02 |
Caucasian-vs-AfricanAmerican |
9.201900E-02 |
Caucasian-vs-Asian |
3.821200E-01 |
AfricanAmerican-vs-Asian |
4.451800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.58879999999839E-05 |
Normal-vs-Female |
5.10260000918805E-09 |
Male-vs-Female |
4.458400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.818180E-03 |
Normal-vs-Extreme_Weight |
2.2772999999976E-05 |
Normal-vs-Obese |
8.3106000000055E-05 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.866200E-01 |
Normal_Weight-vs-Obese |
2.014400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.054400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.204400E-02 |
Normal-vs-Age(41-60Yrs) |
4.352300E-04 |
Normal-vs-Age(61-80Yrs) |
2.73409994644425E-09 |
Normal-vs-Age(81-100Yrs) |
4.134400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.701900E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.042800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.690400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.602100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.923000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.113000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.747600E-01 |
Normal-vs-Grade 3 |
6.040000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.899600E-01 |
Grade 2-vs-Grade 4 |
4.747600E-01 |
Grade 3-vs-Grade 4 |
6.040000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.94139998416421E-09 |
Normal-vs-N1 |
1.259480E-03 |
N0-vs-N1 |
9.933800E-02 |
|
|